Catheter Ablation Improves Mortality and Other Outcomes in Real‐World Patients With Atrial Fibrillation

Author:

Yang Pil‐Sung1,Sung Jung‐Hoon1,Jang Eunsun2,Yu Hee Tae2,Kim Tae‐Hoon2,Uhm Jae‐Sun2,Kim Jong‐Youn2,Pak Hui‐Nam2,Lee Moon‐Hyoung2,Joung Boyoung2

Affiliation:

1. Department of Cardiology CHA Bundang Medical Center CHA University Seongnam Republic of Korea

2. Division of Cardiology Department of Internal Medicine Yonsei University College of Medicine Seoul Republic of Korea

Abstract

Background It is still controversial whether catheter ablation for atrial fibrillation ( AF ) improves survival and other outcomes in patients with AF. This study evaluated whether ablation reduces death and other events in nationwide real‐world Asian patients with AF . Methods and Results From the Korean National Health Insurance Service database, 194 928 adult patients (aged ≥18 years) with newly diagnosed AF were treated with ablation or medical therapy (antiarrhythmic or rate control drugs) between January 1, 2005, and December 1, 2015. Among these patients, this study included 9185 with ablation and 18 770 with medical therapy. The time at risk was counted from the first medical therapy, and ablation was analyzed as a time‐varying covariate. Inverse probability of treatment weighting was used to correct for differences between the groups. After weighting, the 2 cohorts had similar background characteristics. During a median (25th, 75th percentiles) follow‐up of 43 (19, 81) months, ablation of AF was associated with lower incidence and risk of composite outcome, including death, heart failure admission, and stroke/systemic embolism (2.5 and 6.4 per 100 person‐years, respectively; hazard ratio [HR], 0.47; 95% CI , 0.43–0.52; P <0.001), all‐cause death (1.0 and 3.6 per 100 person‐years; HR, 0.41; 95% CI, 0.36–0.47; P <0.001), heart failure admission (0.7 and 1.9 per 100 person‐years; HR, 0.43; 95% CI, 0.37–0.50), and ischemic stroke/systemic embolism (1.1 and 2.8 per 100 person‐years; HR, 0.39; 95% CI, 0.34–0.44) than medical therapy. Conclusions Ablation may be associated with lower risk of death, heart failure admission, and ischemic stroke/systemic embolism in real‐world Asian patients with AF .

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3